Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
3.375
-0.135 (-3.85%)
Apr 25, 2025, 4:00 PM EDT - Market closed

Silence Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
159325672547715611
Upgrade
Market Cap Growth
-51.64%-51.64%22.71%-23.44%17.04%-
Upgrade
Enterprise Value
11152600448612549
Upgrade
Last Close Price
3.366.8817.3715.2523.8922.00
Upgrade
PS Ratio
3.597.5121.2325.2842.5381.67
Upgrade
PB Ratio
1.182.4230.5420.5861.9349.39
Upgrade
P/TBV Ratio
1.282.6157.6633.06580.25487.96
Upgrade
P/FCF Ratio
----96.09-
Upgrade
P/OCF Ratio
----77.58-
Upgrade
EV/Sales Ratio
0.263.5218.9720.6736.4073.34
Upgrade
EV/FCF Ratio
----82.24-
Upgrade
Debt / Equity Ratio
0.000.000.020.020.020.04
Upgrade
Debt / FCF Ratio
----0.03-
Upgrade
Asset Turnover
0.270.270.250.180.140.08
Upgrade
Quick Ratio
10.3610.364.154.035.412.78
Upgrade
Current Ratio
11.1411.144.624.415.692.99
Upgrade
Return on Equity (ROE)
-58.08%-58.08%-223.22%-273.06%-448.22%-217.21%
Upgrade
Return on Assets (ROA)
-19.24%-19.24%-26.32%-26.09%-31.44%-29.33%
Upgrade
Return on Capital (ROIC)
-39.61%-39.61%-132.49%-170.42%-317.04%-126.58%
Upgrade
Earnings Yield
-28.55%-13.95%-8.07%-9.20%-7.46%-7.27%
Upgrade
FCF Yield
-42.76%-20.89%-7.37%-10.45%1.04%-2.52%
Upgrade
Buyback Yield / Dilution
-24.69%-24.69%-15.21%-8.58%-8.78%-8.85%
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q